scispace - formally typeset
J

James M. Downey

Researcher at University of South Alabama

Publications -  385
Citations -  30419

James M. Downey is an academic researcher from University of South Alabama. The author has contributed to research in topics: Ischemic preconditioning & Ischemia. The author has an hindex of 91, co-authored 381 publications receiving 29506 citations. Previous affiliations of James M. Downey include Aventis Pharma & University of South Florida.

Papers
More filters
Journal ArticleDOI

Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.

TL;DR: Adenosine released during the preconditioning occlusion stimulates cardiac A 1 receptors, which leaves the heart protected against infarction even after the adenosine has been withdrawn.
Journal ArticleDOI

Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology

TL;DR: The understanding of the mechanisms associated with preconditioning are unravelled can look forward to the development of new therapeutic agents with novel mechanisms of action that can supplement current treatment options for patients threatened with acute myocardial infarction.
Journal ArticleDOI

Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals.

TL;DR: Mito KATP channels are not the end effectors of protection, but rather their opening before ischemia generates free radicals that trigger entrance into a preconditioned state and activation of kinases, indicating that diazoxide triggers protection through free radicals.
Journal ArticleDOI

Xanthine oxidase as a source of free radical damage in myocardial ischemia.

TL;DR: The infarcts in the allopurinol and superoxide dismutase groups were significantly smaller than those in the control groups, and the xanthine oxidase/xanthine dehydrogenase content of dog myocardium was determined.
Journal ArticleDOI

Preconditioning protects ischemic rabbit heart by protein kinase C activation.

TL;DR: Activation of protein kinase C with 4 beta-phorbol 12-myristate 13-acetate (PMA) or with 1-oleyl-2-acetyl glycerol (OAG) mimicked preconditioning in buffer-perfused hearts, which blocked protection from ischemic preconditionsing in isolated heart.